Journal of the American Society of Hypertension

Official Journal of the American Society of Hypertension Inc. (ASH)

Journal of the American Society of Hypertension - ISSN 1933-1711
Source Normalized Impact per Paper (SNIP): 0.827 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 1.039 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 2.656 (2015) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Thomson Reuters Journal Citation Reports 2015
5 Year Impact Factor: 2.819 (2015) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2014 to the previous five years and divided by the source items published in the previous five years.
© Journal Citation Reports 2015, Published by Thomson Reuters
Volumes: Volume 11
Issues: 12 issues
ISSN: 19331711

Personal Subscription

Shop With Confidence

  • Free Shipping around the world
  • Broad range of products

Description

The Journal of the American Society of Hypertension (JASH) publishes peer-reviewed articles on the topics of basic, applied and translational research on blood pressure, hypertension and related cardiovascular disorders and factors; as well as clinical research and clinical trials in hypertension. Original research studies, reviews, hypotheses, editorial commentary and special reports spanning the spectrum of human and experimental animal and tissue research will be considered. All research studies must have been conducted following animal welfare guidelines. Studies involving human subjects or tissues must have received approval of the appropriate institutional committee charged with oversight of human studies and informed consent must be obtained.

This Journal is covered in MEDLINE, Chemical Abstracts Service, EMBASE, and Scopus.

Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center